Kristine Yaffe1, Daniel Freimer2, Honglei Chen1, Keiko Asao1, Andrea Rosso1, Susan Rubin1, Greg Tranah1, Steve Cummings1, Eleanor Simonsick1. 1. From the Departments of Psychiatry (K.Y.), Neurology (K.Y.), and Epidemiology and Biostatistics (K.Y., S.R.), University of California; San Francisco VA Medical Center (K.Y.); NCIRE-The Veterans Health Research Institute (K.Y., D.F.), San Francisco, CA; Epidemiology Branch (H.C.), National Institute of Environmental Health Sciences, Research Triangle Park, NC; Department of Preventive Medicine (K.A.), University of Tennessee Health Science Center, Memphis; Department of Epidemiology (A.R.), Graduate School of Public Health, University of Pittsburgh, PA; California Pacific Medical Center Research Institute (G.T., S.C.), San Francisco; and Translational Gerontology Branch (E.S.), National Institute on Aging, Baltimore, MD. 2. From the Departments of Psychiatry (K.Y.), Neurology (K.Y.), and Epidemiology and Biostatistics (K.Y., S.R.), University of California; San Francisco VA Medical Center (K.Y.); NCIRE-The Veterans Health Research Institute (K.Y., D.F.), San Francisco, CA; Epidemiology Branch (H.C.), National Institute of Environmental Health Sciences, Research Triangle Park, NC; Department of Preventive Medicine (K.A.), University of Tennessee Health Science Center, Memphis; Department of Epidemiology (A.R.), Graduate School of Public Health, University of Pittsburgh, PA; California Pacific Medical Center Research Institute (G.T., S.C.), San Francisco; and Translational Gerontology Branch (E.S.), National Institute on Aging, Baltimore, MD. kristine.yaffe@ucsf.edu.
Abstract
OBJECTIVE: Prior studies indicate that olfactory function may be an early marker for cognitive impairment, but the body of evidence has been largely restricted to white populations. METHODS: We studied 2,428 community-dwelling black and white older adults (baseline age 70-79 years) without dementia enrolled in the Health, Aging, and Body Composition (Health ABC) study. Olfaction was measured as odor identification (OI) with the 12-item Cross Cultural Smell Identification Test in year 3. We defined incident dementia over 12 years on the basis of hospitalization records, prescription for dementia medication, or 1.5-SD decline in race-stratified global cognition score. We assessed dementia risk associated with OI score (by tertile) using Cox proportional hazards models. All analyses were stratified by race. RESULTS: Poorer OI in older adults without dementia was associated with increased risk of dementia. After adjustment for demographics, medical comorbidities, and lifestyle characteristics, white participants in the poor or moderate OI tertile had greater risk of dementia (adjusted hazard ratio [HR] 3.34, 95% confidence interval [CI] 2.45-4.54; and HR 1.84, 95% CI 1.33-2.54, respectively) compared to those in the good tertile of function. Among blacks, worse OI was associated with an increased risk of dementia, but the magnitude of the effect was weaker (p for interaction = 0.04) for the poor OI tertile (adjusted HR 2.03, 95% CI 1.44-2.84) and for the moderate tertile (adjusted HR 1.42, 95% CI 0.97-2.10). There was no interaction between OI and APOE ε4 and risk of dementia. CONCLUSIONS: While the magnitude of the association was stronger in whites, we found that poor OI was associated with increased risk of dementia among both black and white older adults.
OBJECTIVE: Prior studies indicate that olfactory function may be an early marker for cognitive impairment, but the body of evidence has been largely restricted to white populations. METHODS: We studied 2,428 community-dwelling black and white older adults (baseline age 70-79 years) without dementia enrolled in the Health, Aging, and Body Composition (Health ABC) study. Olfaction was measured as odor identification (OI) with the 12-item Cross Cultural Smell Identification Test in year 3. We defined incident dementia over 12 years on the basis of hospitalization records, prescription for dementia medication, or 1.5-SD decline in race-stratified global cognition score. We assessed dementia risk associated with OI score (by tertile) using Cox proportional hazards models. All analyses were stratified by race. RESULTS: Poorer OI in older adults without dementia was associated with increased risk of dementia. After adjustment for demographics, medical comorbidities, and lifestyle characteristics, white participants in the poor or moderate OI tertile had greater risk of dementia (adjusted hazard ratio [HR] 3.34, 95% confidence interval [CI] 2.45-4.54; and HR 1.84, 95% CI 1.33-2.54, respectively) compared to those in the good tertile of function. Among blacks, worse OI was associated with an increased risk of dementia, but the magnitude of the effect was weaker (p for interaction = 0.04) for the poor OI tertile (adjusted HR 2.03, 95% CI 1.44-2.84) and for the moderate tertile (adjusted HR 1.42, 95% CI 0.97-2.10). There was no interaction between OI and APOE ε4 and risk of dementia. CONCLUSIONS: While the magnitude of the association was stronger in whites, we found that poor OI was associated with increased risk of dementia among both black and white older adults.
Authors: Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider Journal: Arch Neurol Date: 2003-02
Authors: T B Harris; M Visser; J Everhart; J Cauley; F Tylavsky; T Fuerst; M Zamboni; D Taaffe; H E Resnick; A Scherzinger; M Nevitt Journal: Ann N Y Acad Sci Date: 2000-05 Impact factor: 5.691
Authors: Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Carlos Henríquez-Roldán; Norma Osnaya; Angelica González-Maciel; Rafael Reynoso-Robles; Rafael Villarreal-Calderon; Lou Herritt; Diane Brooks; Sheyla Keefe; Juan Palacios-Moreno; Rodolfo Villarreal-Calderon; Ricardo Torres-Jardón; Humberto Medina-Cortina; Ricardo Delgado-Chávez; Mario Aiello-Mora; Robert R Maronpot; Richard L Doty Journal: Exp Toxicol Pathol Date: 2009-03-17
Authors: Latha Velayudhan; Megan Pritchard; John F Powell; Petroula Proitsi; Simon Lovestone Journal: Int Psychogeriatr Date: 2013-04-19 Impact factor: 3.878
Authors: Purnima P Desai; Hugh C Hendrie; Rebecca M Evans; Jill R Murrell; Steven T DeKosky; M Ilyas Kamboh Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2003-01-01 Impact factor: 3.568
Authors: Eli P Darnell; Kristen E Wroblewski; Kristina L Pagel; David W Kern; Martha K McClintock; Jayant M Pinto Journal: Chem Senses Date: 2020-05-29 Impact factor: 3.160
Authors: Frank Purdy; Zhehui Luo; Joseph C Gardiner; Jayant M Pinto; Eric J Shiroma; Eleanor M Simonsick; Tamara B Harris; Honglei Chen Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Dara R Adams; David W Kern; Kristen E Wroblewski; Martha K McClintock; William Dale; Jayant M Pinto Journal: J Am Geriatr Soc Date: 2017-09-25 Impact factor: 5.562
Authors: Maria Vassilaki; Teresa J Christianson; Michelle M Mielke; Yonas E Geda; Walter K Kremers; Mary M Machulda; David S Knopman; Ronald C Petersen; Val J Lowe; Clifford R Jack; Rosebud O Roberts Journal: Ann Neurol Date: 2017-06-09 Impact factor: 10.422
Authors: Priya Palta; Honglei Chen; Jennifer A Deal; A Richey Sharrett; Alden Gross; David Knopman; Michael Griswold; Gerardo Heiss; Thomas H Mosley Journal: Alzheimers Dement Date: 2018-03-30 Impact factor: 21.566